A new drug targeting toxic proteins in the brain shows promise in treating Alzheimer's disease. Researchers developed RI-AG03 to prevent tau protein clumping, a key factor in Alzheimer's progression. Early studies in fruit flies and cells are encouraging, but human trials are needed for further evaluation.